PT  - JOURNAL ARTICLE
AU  - Ellis, Elizabeth G.
AU  - Joutsa, Juho
AU  - Morrison-Ham, Jordan
AU  - Caeyenberghs, Karen
AU  - Corp, Daniel T.
TI  - Localization of Abnormal Brain Regions in Parkinsonian Disorders: An ALE Meta-Analysis
AID  - 10.1101/2022.04.11.22273755
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.04.11.22273755
4099  - http://medrxiv.org/content/early/2022/04/13/2022.04.11.22273755.short
4100  - http://medrxiv.org/content/early/2022/04/13/2022.04.11.22273755.full
AB  - Parkinsonism is a feature of several neurodegenerative disorders, including Parkinson’s disease (PD), progressive supranuclear palsy (PSP), corticobasal degeneration syndrome (CBS) and multiple system atrophy (MSA). Neuroimaging studies have yielded insights into parkinsonism; however it remains unclear whether there is a common neural substrate amongst disorders. The aim of the present meta-analysis was to identify consistent brain alterations in parkinsonian disorders (PD, PSP, CBS, MSA) both individually, and combined, to elucidate the shared substrate of parkinsonism. 33,505 studies were systematically screened following searches of MEDLINE Complete and Embase databases. A series of whole-brain activation likelihood estimation meta-analyses were performed on 126 neuroimaging studies (64 PD; 25 PSP; 18 CBS; 19 MSA) utilizing anatomical MRI, perfusion or metabolism positron emission tomography and single photon emission computed tomography. Abnormality of the caudate, thalamus, middle frontal and temporal gyri was common to all parkinsonian disorders. Localizations of commonly affected brain regions in individual disorders aligned with current diagnostic imaging markers, localizing the midbrain in PSP, putamen in MSA-parkinsonian variant and brainstem in MSA-cerebellar variant. Regions of the basal ganglia and precuneus were most commonly affected in PD, while CBS was characterized by caudate abnormality. To our knowledge, this is the largest meta-analysis of neuroimaging studies in parkinsonian disorders. Findings support the notion that parkinsonism may share a common neural substrate, independent of the underlying disease process, while also highlighting characteristic patterns of brain abnormality in each disorder.Competing Interest StatementThe authors have declared no competing interest.Funding StatementE.G.E is funded by the Deakin University Postgraduate Research Scholarship. J.J has received research grants from the Finnish Medical Foundation, Instrumentarium Research Foundation, Finnish Foundation for Alcohol Studies, University of Turku (private donation, Sigrid Juselius), Turku University Hospital (ERVA funds), and lecturer honoraria from Lundbeck. J.M.H is funded by the Australian Government Research Training Program scholarship. D.T.C and K.C have no funding to disclose.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that support the findings of this study are available from the corresponding author upon request. Code used via Ginger ALE version 3.2 is available through http://brainmap.org.PDParkinson’s diseasePSPProgressive supranuclear palsyCBSCorticobasal degeneration syndromeMSAMultiple System AtrophyAPDsAtypical parkinsonian disordersALEActivation Likelihood EstimationMRImagnetic resonance imagingPETpositron emission tomographySPECTsingle photon emission computed tomography